Xinxin Ci
Impact in
- Pharmacology top 0.5%
- Pharmacological Effects of Natural Compounds
- Drug-Induced Hepatotoxicity and Protection
Papers in
-
- Genomics, phytochemicals, and oxidative stress 23
- Inflammasome and immune disorders 9
- Heme Oxygenase-1 and Carbon Monoxide 6
- Immunology 19
- Immune Response and Inflammation 15
- Co-authors
- Xuming Deng (30 shared papers)Qinmei Liu (4 shared papers)Hongming Lv (5 shared papers)Hongming Lv (8 shared papers)Yun Gao (4 shared papers)Haihua Feng (4 shared papers)Xiaoye Fan (10 shared papers)Zhongmei Wen (5 shared papers)
- Journals
- International Immunopharmacology (6 papers)Frontiers in Pharmacology (5 papers)Inflammation Research (3 papers)Molecules (3 papers)Free Radical Biology and Medicine (3 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Xinxin Ci
76 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Pharmacology 672
- Complementary and alternative medicine 337
- Immunology 730
- Molecular Biology 2.0k
- Cancer Research 372
Countries citing papers authored by Xinxin Ci
This map shows the geographic impact of Xinxin Ci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinxin Ci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinxin Ci more than expected).
Fields of papers citing papers by Xinxin Ci
This network shows the impact of papers produced by Xinxin Ci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinxin Ci. The network helps show where Xinxin Ci may publish in the future.
Co-authors
The 25 scholars most cited alongside Xinxin Ci, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Xanthohumol ameliorates lipopolysaccharide (LPS)-induced acute lung injury via induction of AMPK/GSK3β-Nrf2 signal axis Hit paper breakdown → | 2017 | 358 |
| 2 | 2019 | 224 | |
| 3 | 2019 | 202 | |
| 4 | 2015 | 169 | |
| 5 | 2012 | 149 | |
| 6 | Leonurine alleviates ferroptosis in cisplatin‐induced acute kidney injury by activating the Nrf2 signalling pathway Hit paper breakdown → | 2022 | 135 |
| 7 | 2008 | 133 | |
| 8 | 2016 | 117 | |
| 9 | 2013 | 109 | |
| 10 | 2009 | 104 | |
| 11 | 2012 | 102 | |
| 12 | 2017 | 101 | |
| 13 | 2012 | 101 | |
| 14 | 2017 | 99 | |
| 15 | 2022 | 90 | |
| 16 | 2011 | 88 | |
| 17 | 2017 | 81 | |
| 18 | 2011 | 76 | |
| 19 | 2012 | 71 | |
| 20 | 2018 | 70 |
About Xinxin Ci
Xinxin Ci is a scholar working on Molecular Biology, Immunology, Pulmonary and Respiratory Medicine, Cancer Research and Pharmacology, having authored 77 papers that have together received 4.0k indexed citations. Recurring topics across this work include Genomics, phytochemicals, and oxidative stress (23 papers), Immune Response and Inflammation (15 papers), NF-κB Signaling Pathways (11 papers), Asthma and respiratory diseases (9 papers), Inflammasome and immune disorders (9 papers), Ferroptosis and cancer prognosis (7 papers), Heme Oxygenase-1 and Carbon Monoxide (6 papers) and Air Quality and Health Impacts (5 papers). The work is most often cited by research in Pharmacology (672 citations), Complementary and alternative medicine (337 citations), Immunology (730 citations), Molecular Biology (2.0k citations) and Cancer Research (372 citations). Xinxin Ci has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Xuming Deng, Qinmei Liu, Hongming Lv, Hongming Lv, Yun Gao, Haihua Feng, Xiaoye Fan, Zhongmei Wen, Liping Peng and Xiao Chu. Their work appears in journals such as International Immunopharmacology, Frontiers in Pharmacology, Inflammation Research, Molecules and Free Radical Biology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.